Shopping Cart
- Remove All
Your shopping cart is currently empty
Oxiracetam (ISF2522), a cyclic derivative of gamma-aminobutyric acid (GABA), is utilized for the treatment of cognitive impairments.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $50 | In Stock | |
| 10 mg | $76 | In Stock | |
| 25 mg | $118 | In Stock | |
| 50 mg | $148 | In Stock | |
| 100 mg | $232 | In Stock | |
| 200 mg | $349 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $65 | In Stock |
| Description | Oxiracetam (ISF2522), a cyclic derivative of gamma-aminobutyric acid (GABA), is utilized for the treatment of cognitive impairments. |
| In vitro | In BALB/c mice, Oxiracetam (50 mg/kg i.p.) has been shown to improve avoidance acquisition. Similarly, in rats, pretreatment with Oxiracetam (30 mg/kg) has demonstrated efficacy in ameliorating cognitive deficits induced by trimethyltin. |
| Synonyms | ISF2522 |
| Molecular Weight | 158.16 |
| Formula | C6H10N2O3 |
| Cas No. | 62613-82-5 |
| Smiles | C(C(N)=O)N1CC(O)CC1=O |
| Relative Density. | 1.416 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 10 mg/mL (63.23 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.